Wesley Yin

Wesley Yin

Associate Professor of Public Policy and Management

Education:

Ph.D. in Economics, Princeton University
M.A. in Economics, Princeton University
B.S. in Economics, University of Maryland, College Park
B.A. in Mathematics, University of Maryland, College Park

Areas of Interest:

Economic Development, Economics, Equity, Global Health, Health Care, Labor and Employment

Phone:

(301) 928-4308

Email:

wyin@ucla.edu

Office Location:

6391, Public Affairs

Wesley “Wes” Yin is an associate professor in the UCLA Luskin Department of Public Policy and the Anderson School of Management at UCLA, and is a Faculty Research Fellow at the National Bureau of Economic Research. Prior to coming to UCLA, Wesley served as Acting Assistant Secretary of Economic Policy at the Department of Treasury, and as a Senior Economist in the White House Council of Economic Advisers, in the Obama Administration. He also taught at Boston University and the University of Chicago, and was a Robert Wood Johnson Scholar in Health Policy at Harvard University.

Yin researches health care, economic development, and consumer finance. His current research studies how innovation and policy reforms in health care and social insurance affect consumer health and financial well-being, public finance, and equity.

 

PUBLISHED AND FORTHCOMING ECONOMICS PAPERS

The Market for High-Quality Medicine: Retail Chain Entry and Drug Quality in India (with Daniel Bennett) Review of Economics and Statistics, March 2019, Volume 101(1) p.76-90 [Appendix]

Insurers’ Negotiating Leverage and the External Effect of Medicare Part D (with Darius Lakdawalla), Review of Economics and Statistics,  97:2 p.314-331 May 2015 (an earlier version appears as NBER working paper no. 16251)

R&D Policy, Agency Costs and Innovation in Personalized Medicine, Journal of Health Economics, September 2009, 28(5), pp. 950-962

Market Incentives and Pharmaceutical Innovation, Journal of Health Economics, July 2008, 27(4), pp. 1060-1077

Female Empowerment: Impact of a Commitment Savings Product in the Philippines (with Nava Ashraf and Dean Karlan) World Development, 2010, 38(3), pages 333-344

Tying Odysseus to the Mast: Evidence from a Commitment Savings Product in the Philippines (with Nava Ashraf and Dean Karlan) Quarterly Journal of Economics, May 2006, 121(2). Winner of TIAA-CREF 2006 Certificate of Excellence

Designing Targeting Schemes with Poverty Maps: Does Disaggregation Help? (with Berk Özler, Chris Elbers, Tomoki Fujii, Peter Lanjouw), Journal of Development Economics, May 2007, 83(1)

Deposit Collectors (with Nava Ashraf and Dean Karlan), Advances in Economic Analysis & Policy, March 2006, 6(2), Article 5

 

WORKING PAPERS

The Role of Behavioral Frictions in Health Insurance Marketplace Enrollment and Risk: Evidence from a Field Experiment (with Richard Domurat and Isaac Menashe) [Online Appendix]

Provider Market Power and Adverse Selection in Health Insurance
Markets (with Richard Domurat and Nicholas Tilipman)

 

PUBLISHED POLICY and MEDICAL JOURNAL ARTICLES

Potential Impacts of Graham-Cassidy-Heller-Johnson on Californians and the Individual Health Insurance Market” Covered California Report, September 25, 2017 (w/ John Berko)

Evaluating the Potential Consequences of Terminating Direct Federal Cost-Sharing Reduction (CSR) Funding” Covered California Report, January 26, 2017 (w/Richard Domurat) [Appendix]

Trump’s “populist” economic proposals come with massive catches. Here’s what to watch for.” Vox, November 18, 2016

Strengthening Risk Protection through Private Long-Term Care Insurance. Brookings Institution, Hamilton Project Discussion Paper 2015-06, June 2015

Value of Survival Gains in Chronic Myeloid Leukemia (with John Penrod, J. Ross Maclean, Darius Lakdawalla and Tomas Philipson) American Journal of Managed Care 2012 Nov;18(11 Suppl):S257-64

The impact of Medicare Part D on Medicare-Medicaid Dual-eligible Beneficiaries’ Prescription Utilization and Expenditures (with Caleb Alexander and Anirban Basu), Health Services Research, February 2010, 45(1), pp. 133-151   

Valuing health technologies at NICE: Recommendations for Improved Incorporation of Treatment Value in HTA (with Dana Goldman, Darius Lakdawalla and Tomas Philipson) Health Economics October 2010, 10(11) pp. 1109-1116

The Effect of the Medicare Part D Prescription Benefit on Drug Utilization and Expenditures (with Anirban Basu, James Zhang, Atonu Rabbani, David Meltzer, Caleb Alexander) Annals of Internal Medicine, Lead article, February 2008, 148:3 pp. 169-177

Solutions and Challenges to Curing Global Health Inequality Innovations 2(4), October 2007, 2(4), pp. 72-80

Impact of the Medicare Part D prescription benefit on use of generic drugs and different therapeutic drug classes (with James Zhang and Caleb Alexander) The Journal of General Internal Medicine, October 2008, 23:10 pp. 1673-1678

Testing Savings Product Innovations Using an Experimental Methodology (with Nava Ashraf and Dean Karlan), Asian Development Bank, Economics and Research Department Technical Paper No. 8. November, 2003

A Review of Commitment Savings Products in Developing Countries (with Nava Ashraf, Nathalie Gons and Dean Karlan), Asian Development Bank, Economics and Research Department Working Paper No. 45 June, 2003

 

CURRENT TEACHING

Econometrics (MPP Core) (PP208)

Public Finance (and the Economics of Inequality) (Econ 415)

Health Care Finance and Management (MBA and MPP elective) (MGMT298 & PP290)